BRIEF-GSK CEO says U.S. uptake of Anoro more rapid than Breo

July 23 Wed Jul 23, 2014 10:58am EDT

July 23 (Reuters) - GlaxoSmithKline Plc analyst call: * CEO says U.S. pickup of new lung drug Anoro much more rapid than Breo * CFO says no change to dividend policy

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.